Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine
Novel prognostic scoring system for diffuse large B-cell lymphoma
Overall survival curves of patients with primary gastric diffuse large... | Download Scientific Diagram
H&E and immunohistochemical stain images of 209 cases of diffuse large B-cell lymphoma linked with cytogenetic features and clinical outcomes (DLBCL-Morphology) - The Cancer Imaging Archive (TCIA) Public Access - Cancer Imaging
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.
Overall survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Diffuse Large B-cell Lymphoma Prognosis Calculator
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
Diffuse large B cell lymphoma: Outlook, stages, treatment
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
CDHB Red Book
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Flowchart of the survival analysis of patients with diffuse large... | Download Scientific Diagram
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma – Karyopharm Therapeutics
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Immunohistochemical Distinction Between Diffuse Large B-Cell... | Download Table
NHL & CLL Dosing Regimens | RITUXAN® (rituximab)
